Cite
MLA Citation
H. Rugo et al.. “Safety outcomes from monarchE: Phase 3 study of abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER-2-, node-positive, high risk, early breast cancer.” Breast, vol. 56, n.d., pp. S23–S24. http://access.bl.uk/ark:/81055/vdc_100123988441.0x000025